These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 897846)

  • 1. The metabolism of phenobarbitone, phenytoin and antipyrine in Black patients.
    Buchanan N; Bill P; Moodley G; Eyberg C
    S Afr Med J; 1977 Aug; 52(10):394-5. PubMed ID: 897846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of anticonvulsants and haematological sequelae in black epileptics.
    Buchanan N; Bill P; Strickwold B; Eyberg C; Moodley GP; Fernandes Costa F
    S Afr Med J; 1977 Apr; 51(15):504-8. PubMed ID: 857325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of phenobarbitone and phenytoin to kwashiorkor serum.
    Buchanan N; van der Walt LA
    S Afr Med J; 1977 Sep; 52(13):518-21. PubMed ID: 72418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
    Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
    East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The investigation of phenobarbitone, phenytoin and primidone in the death of epileptics.
    Bruce AM; Smith H
    Med Sci Law; 1977 Jul; 17(3):195-9. PubMed ID: 886935
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
    Lambie DG; Johnson RH; Nanda RN; Shakir RA
    Lancet; 1976 Aug; 2(7982):386-9. PubMed ID: 73851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.
    Bekele G; Abebe Y; T'Haimanot R
    Ethiop Med J; 1990 Jan; 28(1):23-30. PubMed ID: 2307155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
    Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
    Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity.
    Richens A; Makki K; Monks A; Oxley J; Laidlaw J
    Monogr Neural Sci; 1980; 5():221-8. PubMed ID: 6798427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
    Neuvonen PJ; Tokola RA; Kaste M
    Eur J Clin Pharmacol; 1981; 21(3):215-20. PubMed ID: 7318881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.
    Houghton GW; Richens A; Toseland PA; Davidson S; Falconer
    Eur J Clin Pharmacol; 1975 Oct; 9(1):73-8. PubMed ID: 1233256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin does not affect antipyrine clearance.
    Allen E; Tsanaclis LM; Wroe SJ; Reece PA; Sedman AJ
    J Clin Pharmacol; 1999 Sep; 39(9):934-5. PubMed ID: 10471984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin and phenobarbitone plasma level-dose relationships in Chinese epileptic children in Singapore.
    Lee HS; Chan KY
    Ther Drug Monit; 1981; 3(3):247-52. PubMed ID: 7324089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.
    Mucklow JC; Bacon CJ; Hierons AM; Webb JK; Rawlins MD
    Ther Drug Monit; 1981; 3(3):275-7. PubMed ID: 7324092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.